Artificial Intelligence solutions for healthcare delivery
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
miRNAs in brain cancer therapy – Mighty things from small beginnings grow
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
The rise of men with skin cancer: Raising awareness
We spoke to Dr Paul Banwell about the rise of men with skin cancer and how it’s vital to talk about it and raise...
COVID vaccine: Parental hesitancy for kids with cancer
A survey shows parents of kids with cancer have similar hesitancy rates as the wider population to vaccinate their children against COVID-19.
Better prognosis identification with prostate cancer urine tests
Researchers at University of East Anglia have discovered that a prostate cancer urine test could improve the identification of men at ‘immediate risk’ of aggressive cancer, offering improved treatment methods.
Finalising a home test kit for breast cancer patients
A home test kit enabling patients with Breast cancer to test their blood nears its final development stages, with support from the NHS and inventors Entia and Pfizer.
Early detection of pancreatic cancer – The EUROPAC Research Trial
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about the European pancreatic cancer early detection trial (EUROPAC).
HPV immunisation programme reduces cervical cancer by 90%
Breakthrough in cancer research as the human papillomavirus (HPV) immunisation programme substantially reduces cervical cancer by nearly 90% across the UK.
Scientists create new test for aggressive childhood brain tumours
The new test could single out childhood brain tumours which are "the most aggressive forms of medulloblastoma" - which would lead to a better, more specific treatment.
Third of leukaemia patients show no COVID-19 antibody response
According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.
New cancer treatment creates best “overall survival ever”
A new cancer treatment, an immunotherapy combination as opposed to gruelling chemotherapy, is saving the lives of head and neck cancer patients.
Black women face racial disparities in breast cancer screening
Black women face higher mortality rates and recurrence of breast cancer, according to researchers from University of Illinois Chicago.
Establishing health priorities in Japan
Investigating the current and future health priorities of Japan’s Ministry of Health, Labour and Welfare, including an increasing focus on cancer research.
Our friends oncolytic – using viruses to cure cancer
Sean E. Lawler PhD from Brown University Cancer Center, walks us through our friends oncolytic, or in other words, using viruses to cure cancer.
Non-melanoma skin cancers & malignant melanoma
Prof Dangou from the WHO Regional Office for Africa, Congo, speaks about the different kinds of skin cancer:non-melanoma skin cancers and malignant melanoma.
Ultraviolet radiation and skin cancer
Dr Paul Banwell leading plastic surgeon and expert in skin cancer, walks us through what we need to know about ultraviolet radiation and skin cancer.
The future of cancer diagnostics
CEO of Dxcover Limited, Mark Hegarty, offers an insight into their cutting-edge technology that can help save lives by detecting early signs of cancer.
A look at brain tumour diagnosis & therapy
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
Apoptosis: A key alternate trigger of carcinogenesis
Chanda Siddoo-Atwal, President and Primary Biochemist of Moondust Cosmetics Ltd., explores apoptosis, a key alternate trigger of carcinogenesis.
The EU needs a new Marshall Plan for oncology
Małgorzata Anna Bogusz, Rapporteur of the EESC opinion SOC/677 – Europe’s beating cancer plan, argues here that the EU needs a new Marshall Plan for oncology.